Patents by Inventor Barbara A. Chicca

Barbara A. Chicca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolic gene polynucleotides and polypeptides and uses thereof
    Patent number: 7348406
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: March 25, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Mary Ruth Erickson, Barbara A. Chicca, Bernard Bihain, Hiroaki Tanaka
  • GMG-3 GMG-4 and GMG-6 polynucleotides and polypeptides and uses thereof
    Patent number: 7326678
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: February 5, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Mary Ruth Erickson, Barbara A. Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno P. Dialynas, Aaron Scalia
  • GSSP4 polynucleotides and polypeptides and uses thereof
    Patent number: 7223727
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP4 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing cholesterol levels, body mass, body fat, and for treating metabolic-related diseases and disorders. The metabolic-related diseases or disorders include, but are not limited to, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, diabetes, glucose intolerance, insulin resistance and hypertension.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: May 29, 2007
    Assignee: Serono Genetics Institute S.A.
    Inventors: Barbara Chicca, John Chicca, Blake Denison, Frances Yen-Potin, Bernard Bihain, Stephane Bejanin, Hiroaki Tanaka, Severin Jobert, Jean-Yves Giordano, Jean-Baptiste Dumas Milne Edwards
  • Metabolic gene polynucleotides and polypeptides and uses thereof
    Publication number: 20060247160
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: January 15, 2002
    Publication date: November 2, 2006
    Applicant: Genset S.A.
    Inventors: Mary Ruth Erickson, Barbara Chicca, Bernard Bihain, Hiroaki Tanaka
  • Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
    Publication number: 20050239696
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: January 15, 2002
    Publication date: October 27, 2005
    Applicant: Genset S.A.
    Inventors: Mary Erickson, Barbara Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno Dialynas, Aaron Scalia
  • Gssp3 polynucleotides and polypeptides and uses thereof
    Publication number: 20040235709
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP3 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: March 8, 2004
    Publication date: November 25, 2004
    Inventors: Luisa Salter-Cid, Dana Ebbets-Reed, Barbara A. Chicca, John Chicca, Frances Yen-Potin, Bernard Bihain